Related Experiment Video

Updated: Jun 3, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease

Mehmet Kanbay1, Mahmut Ilker Yilmaz, Alper Sonmez

  • 1Division of Nephrology, Gulhane School of Medicine, Ankara, Turkey. drkanbay@yahoo.com

American Journal of Nephrology
|March 11, 2011
PubMed

Insights

High uric acid levels in chronic kidney disease (CKD) patients are linked to endothelial dysfunction. This study confirms that elevated serum uric acid independently predicts impaired vascular function in CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Elevated serum uric acid is linked to endothelial dysfunction and inflammation, common in chronic kidney disease (CKD).
  • Endothelial dysfunction contributes to cardiovascular complications in CKD patients.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and endothelial dysfunction in patients with recently diagnosed CKD.
  • To determine if serum uric acid is an independent predictor of endothelial dysfunction in CKD.

Main Methods:

  • Evaluated 263 patients with stage 3-5 CKD using ultrasonographic flow-mediated dilatation (FMD) to assess endothelial function.
  • Excluded patients with diabetes, cardiovascular complications, or those taking interfering medications to minimize confounding factors.

Main Results:

  • Serum uric acid levels were significantly increased across all CKD stages and inversely correlated with FMD (r = -0.49, p < 0.001).
  • This association persisted after adjusting for multiple confounding variables, including age, gender, lipids, and inflammation markers (β = -0.27, p < 0.001).

Conclusions:

  • Increased serum uric acid is an independent predictor of endothelial dysfunction in individuals with CKD.
  • Managing uric acid levels may be a therapeutic target to improve vascular health in CKD patients.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...